All stocks / ISCO
International Stem Cell CORP ISCO
International Stem Cell (ISCO): 2 insider sales or sale notices in 90 days and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- INTERNATIONAL STEM CELL CORPORATION
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- Nov 16
- Website
- www.internationalstemcell.com
The financial report, and what it means
Annual figures to 2025-12-31- Revenue
- $9,100,000
- Net loss
- ($418,000)
It spends more than it earns
Under strainCustomers paid it $9.1 million in the year. It lost $418,000. For every $1 that came in, about $1.05 went out.
- Cash and cash equivalents
- $993,000
- Net cash from operating activities
- $8,000
The business brings in cash
SteadyDay-to-day business added $8,000 in cash over the year. It had $993,000 in the bank.
- Total assets
- $4,819,000
- Total liabilities
- $4,579,000
It owns more than it owes
SteadyEverything the company owns adds up to $4.8 million. Its debts and unpaid bills add up to $4.6 million. That is about $0.95 owed for every $1 owned.
What this adds up to
1 of 3 checks show strain. It spends more than it earns. These are facts from the company's own reports, not a recommendation.
Signals
MAIER PAUL V reported selling 32,802 shares for about $10,497 (Form 4, 2026-09-11).
Rule: Form 4 or Form 144 sale in the last 90 days. Source record
MAIER PAUL V filed notice of a proposed sale of 32,802 shares (Form 144, 2026-09-11).
Rule: Form 4 or Form 144 sale in the last 90 days. Source record
Estimated float about 8,004,389 shares as of 2026-08-11: 8,004,389 outstanding minus 0 held by 1 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about ISCO
Does ISCO file reports with the SEC?
Yes. International Stem Cell files with the SEC under company number 0001355790. The most recent filing we hold is a 4 dated 2026-09-17.
Source recordHow many ISCO shares are outstanding?
8,004,389 shares as of 2026-08-11, as reported to the SEC.
Source recordHas ISCO filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Have ISCO insiders sold shares recently?
2 insider sales or sale notices were filed in the last 90 days. Most recent: MAIER PAUL V reported selling 32,802 shares for about $10,497 (Form 4, 2026-09-11).
Source recordIs International Stem Cell making money?
Customers paid it $9.1 million in the year. It lost $418,000. For every $1 that came in, about $1.05 went out. (Annual figures to 2025-12-31. Facts from the company's own report, not a recommendation.)
Source record